1. Introduction {#sec1}
===============

Injury to the spinal cord presents a significant clinical and therapeutic problem ([Table 1](#t0005){ref-type="table"}) that includes significant neuropathic pain syndromes. While most spinal cord injuries are in adults, both traumatic and non-traumatic injuries present in children, with the most common being neoplasms and vascular ([@ref1]) and demyelinating diseases including acute transverse myelitis ([@ref2]; [@ref3]). Transverse myelitis is "a neurological disorder caused by inflammation across both sides of one level, or segment, of the spinal cord" ([@ref4]). The term 'myelitis' refers to inflammation of the spinal cord while the term 'transverse' refers to the location of the inflammation across the width of the spinal cord.

Acute transverse myelitis may occur as an isolated inflammatory process or as part of a chronic demyelinating disorder such as multiple sclerosis (MS), neuromyelitis optica (NMO), acute disseminated encephalomyelitis (ADEM) or a syndrome characterized as polio-like myelitis or acute flaccid myelitis ([@ref5]; [@ref6]; [@ref7]). Transverse myelitis can be classified into two types: *complete or partial*. Complete transverse myelitis usually involves major bilateral loss in motor, sensory and sphincter function. It can be associated with a long spinal cord lesion exceeding three vertebral bodies in length, referred to as Longitudinally Extensive Transverse Myelitis (LETM).

Damage resulting from the inflammation to the fibers in the spinal cord tracts results in a constellation of symptoms and signs characteristic of spinal cord damage including pain, weakness or paralysis, urinary retention and loss of control of bowel function. In some patients there is complete recovery, while in others, these symptoms, including pain, may persist for years. Routine Magnetic Resonance Imaging (MRI) has been the imaging modality of choice in the detection of neuroinflammation; however, studies have shown it to have poor correlation with clinical status of patients with demyelinating injuries ([@ref8]; [@ref9]; [@ref10]; [@ref11]). Finding more sensitive approaches to defining the location, severity and evolution (i.e., persistence or recovery) of regional demyelination may contribute to a more informed approach to diagnosis and treatment.

Pain in spinal cord disease is frequently severe and disabling ([@ref12]). The incidence of pain is reported in approximately 65% of patients with chronic SCI, with nearly one third of these patients rating their pain as severe ([@ref13]; [@ref14]; [@ref15]). The pain may be musculoskeletal, neuropathic and less commonly visceral. In spinal cord demyelination, pain is believed to develop following damage to the spinothalamic pathways that under normal condition carry nociceptive information to the brain ([@ref16]; [@ref17]). Symptomatically, these changes result in pain at and below the level of the damage.

In this review we summarize (1) spinal cord demyelinating conditions in the pediatric population; (2) their distinguishing features; and (3) classification methods in spinal cord disease with particular focus on pain. We also focus on the current and developing approaches to objective measures of spinal cord damage and recovery using different MRI methods.

1.1. Search terms and methodology {#sec1.1}
---------------------------------

English language literature search of demyelination of spinal cord in children and MRI measures in pain was undertaken using PubMed ([[http://www.ncbi.nlm.nih.gov/pubmed]{.ul}](http://www.ncbi.nlm.nih.gov/pubmed){#interref117}) from inception until March 2015. Keywords included the terms 'demyelination', 'myelitis', 'spinal cord', 'pediatric', 'neuropathic pain' and 'imaging'. Of note, using search terms "pediatric AND myelitis AND pain AND diffusion" yielded no results suggesting a paucity of information in the field.

2. Pediatric spinal cord demyelination {#sec2}
======================================

Inflammatory demyelinating myelopathies represent the majority of pediatric non-traumatic SCI ([@ref2]; [@ref8]). These are often grouped under the term "*myelitis*" which comprises acute transverse myelitis, NMO and spinal cord relapses in MS. Each year, an estimated 1400 new cases of acute transverse myelitis occur in the United States ([@ref11]). Among these cases, 20% are reported in children less than 18 years of age ([@ref9]). Transverse myelitis was believed to affect males and females equally with a reported 1.04 ratio ([@ref10]). However a more recent study showed a slight male predominance (ratio = 1:0.9) in children less than 10 years of age and a female predominance (ratio = 1:1.2) in patients older than 10 years ([@ref11]). The reason for these disparities remains unclear. Demyelination is believed to be the pathological basis in transverse myelitis and presents acutely in children, with symptoms appearing over 24--48 h ([@ref4]; [@ref18]).

2.1. Diagnosis of transverse myelitis {#sec2.1}
-------------------------------------

In 2002, the Transverse Myelitis Consortium Working Group established criteria for diagnosis of acute transverse myelitis ([@ref19]). The diagnosis requires patients to undergo lumbar puncture to assess Cerebrospinal Fluid (CSF) white blood cells and IgG index and un-enhanced or gadolinium-enhanced MRI of the brain and spinal cord ([@ref20]; [@ref21]; [@ref22]).

The typical pathological features of the disease process, as indicated by T2-weighted MRI ([Fig. 1](#f0005){ref-type="fig"}A--C), include cord enlargement and a focal increase in signal intensity. Some lesions may involve both transverse halves of the cord leading to the interruption of the spinal cord pathways ([@ref23]). More pronounced changes in white matter than in gray matter were reported in one study ([@ref24]) while another study reported both gray and white matter regions to be equally damaged in transverse myelitis ([@ref25]).

At onset, myelitis is manifested by a spectrum of symptoms including limb weakness, sensory disturbance, back pain, and bladder and bowel dysfunction. Symptoms are sudden and progress rapidly over a few hours to a few days. It has been reported that 45% of patients worsen within 24 h ([@ref25]) and children less than 3 years old whose deficits reached maximal severity in less than 24 h of onset are less likely to regain full ambulatory ability ([@ref8]; [@ref10]; [@ref16]).

2.2. Disease prognosis and long-term consequences {#sec2.2}
-------------------------------------------------

Despite the unfavorable statistics on myelitis-related complications, children and young adults with this disorder show a more favorable outcome in neurological recovery compared with adults ([@ref9]). Overall, 30--62% of patients with transverse myelitis have long-term neurological deficits ([@ref9]) but may vary in degree. For example, 80% of children reportedly recovered to independent ambulation ([@ref8]) and a study conducted on 95 children showed that 70% experienced full physical recovery and 30% had deficits in gait and bladder/bowel function ([@ref26]).

When any spinal cord disease occurs at a young age, patients are at high risk for scoliosis development ([@ref27]). In a retrospective study of 130 patients injured between birth and the age of 21 years, 97% of patients injured before the growth spurt developed scoliosis compared to 52% injured after adolescent growth spurt ([@ref28]). These numbers were further validated by Apple and associates who reported that scoliosis developed in 23% of children with SCI younger than 12 years of age compared to only 5% of adults ([@ref29]). The patients studied included both traumatic and non-traumatic injuries. Longitudinal studies are needed to examine inquired scoliosis in children with myelitis.

2.3. Classification methods in spinal cord disease {#sec2.3}
--------------------------------------------------

### 2.3.1. The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) {#sec2.3.1}

Since their first edition in 1982, the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) have progressively improved and are now adopted world-wide as a method to evaluate and classify the neurological consequence of spinal cord injury ([@ref30]; [@ref31]). The evaluation involves strength testing of ten muscles in the upper limb and ten muscles in the lower limb, sensory testing to light touch and sharp--dull discrimination by way of pin-prick and, evaluation of deep anal pressure and contraction. Scores from the evaluation are used to classify, among other injury characteristics, the neurological, motor and sensory levels and the severity of injury (complete\\incomplete). The determination of complete or incomplete is based on sensory examination at the S4--5 dermatome and results of the anorectal examination. The ISNCSCI are used in the classification of traumatic and non-traumatic SCI for all age groups and are the recommended method for evaluating acute neurological status and also for recording neurological recovery over time ([@ref32]; [@ref33]; [@ref34]; [@ref35]). There are no studies testing the validity and sensitivity of the ISNCSCI in pediatric non-traumatic SCI. Thus, the inability to reliably evaluate the consequence of myelitis using the ISNCSCI and to classify the severity of injury in children may pose considerable barriers to prognostication of recovery, definition of rehabilitation goals and evaluation of clinical trials designed for neurorepair and neurorecovery.

### 2.3.2. The Expanded Disability Status Scale (EDSS) {#sec2.3.2}

The Expanded Disability Status Scale (EDSS) was developed in 1983 and has been widely used as a primary endpoint to measure impairment in clinical trials of MS ([@ref36]). The EDSS allows clinicians to categorize and score patients\' disability in eight functional systems: pyramidal, cerebral, brainstem, sensory, bowel and bladder, visual and cerebellar. Outcome measures receive scores ranging from 0.0 to 10.0 with half-point increments. In a study involving children with spinal cord inflammatory diseases the EDSS has been applied, in combination with the ISNCSCI, to identify early prognostic factors of relapse and disability ([@ref26]). In adult patients with spinal cord lesions, scores from EDSS were used to evaluate disability and monitor treatment progress in patients with NMO ([@ref37]) and were shown to correlate with results from diffusion tensor imaging in patients with MS and NMO ([@ref38]).

3. Pain in myelitis {#sec3}
===================

3.1. Pain prevalence {#sec3.1}
--------------------

Approximately 40--80% of persons with myelitis report pain as one of the earliest symptoms ([@ref39]). In a study of 24 children with acute transverse myelitis, 88% suffered from pain and 70% of these patients reported that pain interfered with their daily physical activities and rehabilitation efforts ([@ref16]). Data from studies in both pediatric and adult populations indicate that chronic pain in childhood is predictive of pain, disability, and psychiatric disorders in adulthood ([@ref40]; [@ref41]). We are unaware of any studies evaluating the temporal course of pain in children with myelitis, although, in adults, pain symptoms persist even after recovery from transverse myelitis ([@ref4]; [@ref16]; [@ref42]).

3.2. Pain assessment {#sec3.2}
--------------------

Pain assessment in SCI is generally performed using the International Spinal Cord Injury Pain Classification (ISCIP) system ([@ref43]). The classification system places SCI-related pain into four categories, namely, neuropathic, nociceptive, unknown and pain of other etiology. The predominant pain process is neuropathic pain. *Neuropathic pain* is defined by the International Association for the Study of Pain (IASP) as pain triggered by a lesion or disease to the somatosensory nervous system ([@ref44]). It is generally described as a burning, aching, tingling or stabbing sensation. Neuropathic pain is divided into three subtypes: at level SCI pain, below level SCI pain and other neuropathic pain. It is important to note that term level refers to the neurological level of injury defined by the ISNCSCI as the lowest (most caudal) dermatome or myotome with normal sensory and motor function. Neuropathic pain can be unilateral or bilateral and can occur in complete or incomplete injuries. In a study on the prevalence of neuropathic pain in non-traumatic SCI, 15% of the patients reported pain at injury level while 23% had below level pain ([@ref40]). One study mentioned neuropathic pain above injury level possibly due to complex regional pain syndromes and compressive peripheral neuropathy ([@ref45]).

A number of tools are being developed and used in the screening and assessment of SCI-related pain. Despite its somewhat subjective nature, Quantitative Sensory Testing (QST) has been well investigated in patients with SCI. The test uses thermal, electrical and vibratory stimuli administered at different dermatomes to detect the pain thresholds ([@ref46]; [@ref47]). The assessment of pain intensity is often performed using questionnaires and self-reported scales. The Visual Analogue Scale (VAS), Numeric Rating Scale (NRS), Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and PainDETECT questionnaire (PD-Q) provide an estimation of pain and information on pain evolution over time and the effect of treatment ([@ref43]; [@ref48]; [@ref49]; [@ref50]; [@ref51]). These pain assessment methods have been tested extensively in the adult population and in traumatic injuries. The types of pain experienced by individuals with myelitis may be caused by different underlying physiological mechanisms than traumatic injury. Given the high prevalence of pain in children with myelitis, a validated assessment and classification system for pain needs to be established in order to identify characteristic features of pain and determine suitable treatment.

3.3. Pain pathways in myelitis pathogenesis {#sec3.3}
-------------------------------------------

Pain sensation follows a series of mechanisms and pathways integrated from the peripheral nerves to higher cerebral structures. Pain related to transverse myelitis is poorly understood. However, pain from spinal cord injuries and pain associated with MS were reported to result from damage to any structure on the spinothalamic pathway or from demyelination of the dorsal column primary afferents ([Fig. 2](#f0010){ref-type="fig"}) ([@ref52]; [@ref53]). The sequence of events leading to pain in patients with myelitis may start following a lesion involving the dorsal horn of the spinal cord, and subsequently alterations in the myelinated, thinly myelinated and unmyelinated axons of the A- and C-nociceptor fibers as they terminate at the spinal substantia gelatinosa (lamina II). Consequently, the injured/demyelinated afferent axons will exhibit a reduction in electrical conduction ([@ref54]) and a change in electrophysiological properties leading to the generation of ectopic signals. Ectopic discharge has been best evaluated in the peripheral nervous system for C-fibers ([@ref55]) and A-beta fibers ([@ref56]). Such changes in electrical activity may contribute to central sensitization and the sensation of pain at the level of the brain. Pain signals are relayed through the dorsal column of the spinal cord, and ascend contralaterally to the thalamus via the spinothalamic pathway. The pain sensory signals terminate in a number of brain regions including the primary and secondary somatosensory cortices, the posterior insula cortex as well as other brain regions involved in emotional processing ([@ref57]). Several zones in the brain are implicated in pain regulation or modulation: a number of cortical and subcortical regions have outputs to descending modulatory regions in the brainstem ([@ref58]). The periaqueductal gray (PAG) is the primary control center for descending pain modulation ([@ref59]) and receives input from various structures in the brain. PAG neurons send descending axons to the rostral ventromedial medulla (RVM) ([@ref60]) and axons in the RVM project to the spinal cord dorsal horn where they depress the activity of nociceptive neurons ([@ref61]). We are unaware whether these descending pathways are altered in transverse myelitis, but these changes could conceivably contribute to diminished descending modulation of pain.

### 3.3.1. Pain mechanisms in transverse myelitis {#sec3.3.1}

Though the mechanisms underlying lesion development and evolution in myelitis remain unknown, the current theory of pathogenesis suggests that when an infection presents in the immune system with an antigen similar to myelin, the resulting antibodies eventually attack myelin ([Fig. 3](#f0015){ref-type="fig"}). The cascade of pathological events leading to demyelination include peripheral interactions between activated lymphocytes and immunoglobulins, followed by focal monocyte and lymphocyte infiltrates into the spinal cord perivascular space. The disruption of the blood brain barrier permeability leads to a cellular influx of leukocytes (such as eosinophils and neutrophils) and an activation of astrocytes and glial cells, finally leading to local inflammation, oligodendrocyte death and axonal conducting abnormalities ([@ref20]; [@ref25]; [@ref62]; [@ref63]). The inflammatory lesions can occur at the gray matter anterior horns or along the spinothalamic pathway thereby perturbing transmission of pain signals.

This complex circuitry of pain mechanisms is well understood in spinal cord injuries but not in pediatric myelitis where potential restoration of function is more likely. Future research needs to identify demyelination-related pain, explore cellular interactions in the spinal cord dorsal horn, and track all the affected pathways at different disease stages. Mechanism-based research employing advanced imaging techniques and appropriate animal models will allow improved targeted pharmacological treatments and successful clinical trials.

Little is known about how central white matter changes in the spinal cord may produce neuropathic pain. Damaged white matter spinal cord tract may potentially lead to abnormal or ectopic discharges that have been associated with neuropathic pain as measured in peripheral nerves ([@ref139]; [@ref140]). General alterations in nerve function may include trans-synaptic changes or alterations in neurotransmitter systems. Lesions of the dorsal columns show relatively little spontaneous ectopic discharge, but activity may be enhanced by peripheral afferent traffic ([@ref66]). While unknown, alterations in spinal cord axons may have enhanced activity as surmised by clinical evidence of processes such as allodynia reflecting alterations between damaged and intact neurons ([@ref67]). We are unaware of transverse myelitis affecting the short processes of interneurons, a consideration in the potential manifestation of pain. Potential support for alterations in interneurons includes (1) that interneuronitis may contribute to motor spasms in the spinal cord in patients with acute myelitis ([@ref68]); (2) in peripheral neuropathic pain, selective loss of GABAergic interneurons has been reported ([@ref69]); and (3) the loss of spinal GABAergic interneurons has been reported in spinal cord injury and was associated with neuropathic pain ([@ref70]).

4. Imaging spinal cord disease {#sec4}
==============================

MRI has brought major contributions to the diagnosis and monitoring of myelitis. The routine imaging protocol includes spin-echo or fast spin-echo T1-weighted and T2-weighted sequences, usually in the sagittal and axial planes pre-contrast. If a lesion is observed, post-gadolinium pulse sequences are applied ([@ref71]). Although routine MRI is the modality of choice in the evaluation of pediatric myelitis, studies have shown it to have poor correlation with clinical status of patients with myelitis ([@ref16]; [@ref23]; [@ref73]; [@ref74]). Authors report poor lesion detection in young children with mild acute myelitis and question the specificity of MRI in detecting transverse myelitis because other demyelinating disorders can mimic it by MRI criteria ([@ref71]; [@ref75]). It is suggested to conduct a follow-up scan 24--48 h later if the initial gadolinium-enhanced MRI scan is negative ([@ref76]). However, pediatric transverse myelitis has a high risk of permanent disability. Its symptoms are sudden and progress rapidly over a few hours to a few days. There is a need for timely and accurate imaging protocols with high sensitivity and specificity to discriminate between different demyelinating myelopathies.

4.1. Diffusion tensor imaging (DTI) {#sec4.1}
-----------------------------------

New neuroimaging techniques have proven successful in providing additional information about spinal cord integrity in vivo. One such technique is DTI. It quantifies diffusion of water molecules in each voxel of an image in directions parallel and transverse to the plane of neuronal axons. The unique anisotropic characteristics of the spinal cord may allow DTI to localize white matter, separate white from gray matter and assess structural damage of the cord. Fractional Anisotropy (FA), Axial Diffusivity (AD) and Radial Diffusivity (RD) are parameters derived from DTI calculations and reflect, respectively, the magnitude of anisotropy, diffusivity parallel to the spinal cord tracts and diffusivity perpendicular to the spinal cord tracts.

Since the first in-vivo DTI study of the human spinal cord in 1999, ([@ref77]) various technical limitations have been reported. These are posed by the small cord volume, natural curvature, CSF pulsatile motion, respiratory and cardiac movements, susceptibility artifacts from adjacent tissue interfaces, and in pediatric imaging especially, there is the added possibility of increased subject motion. Most of these challenges are being addressed by improved receiver coils, fast imaging techniques, motion reduction during the scans, motion correction post-scans and cardiac/respiratory gating.

Studies reported the ability of DTI to detect changes in diffusion characteristics along the spinal cord and differences in these parameters between the healthy and traumatically injured spinal cord ([@ref78]; [@ref79]; [@ref80]; [@ref81]). In the injured spinal cord, quantitative analysis of DTI parameters typically reveals a reduction in FA and an increase in diffusivity values (AD, RD and MD). These findings are generally attributed to the breakdown of the longitudinal order given by the axonal membranes and/or myelin sheaths. Anisotropic water diffusion is attributed to the ordered arrangement of myelinated axonal fiber tracts in white matter. In the case of tissue destruction where this order is affected, anisotropy is lost leading to a reduction in FA. These pathological features are not quantifiable on conventional MRI; giving DTI significant clinical value for examining the integrity of highly ordered white matter tissue. [Tables 2 and 3](#t0010 t0015){ref-type="table"} provide an overview on DTI parameters in the healthy and injured spinal cord in the adult and pediatric populations.

Some authors describe improved resolution with small field-of-view imaging techniques ([@ref82]; [@ref83]; [@ref84]; [@ref85]). This technique helped in the differentiation between white and gray matter and subsequently, correlate imaging results with clinical measures at the dorsal and ventral areas of the spine. Specifically, studies indicate that FA, AD, and RD correlate strongly with motor and sensory scores from ASIA examinations ([@ref86]; [@ref87]; [@ref88]; [@ref89]). One study reported DTI to correlate with motor scores but was not sensitive in the detection of sensory information ([@ref113]). Moreover, a study on adults with transverse myelitis reported FA to be more sensitive to detect abnormalities than T2-weighted MRI ([@ref134]). Additional reports showed correlation between DTI parameters and severity of demyelination ([@ref92]; [@ref93]) and a reduction in DTI values in regions remote from the injury site suggesting its ability to detect Wallerian axonal degeneration ([@ref87]). Additionally, DTI-based visualization methods, such as tractography, can be used for mapping white matter fiber tract trajectories ([@ref94]). Tractography results were reported to be successful in identifying viable spinal cord fibers in locations that were normal on T2-weighted images but had abnormal FA values ([@ref93]).

4.2. Magnetization transfer imaging (MTI) {#sec4.2}
-----------------------------------------

MTI is the process by which protons associated with unbound water molecules exchange their spin energy with protons bound to macromolecules (lipid content in axonal myelin) ([@ref95]; [@ref96]). When a saturation off-resonance pulse is applied, energy (magnetization) from the pool of bound molecules will move (transfer) to the pool of unbound molecules, reducing the total observed MR signal, thereby providing an indirect marker for myelin content ([@ref97]; [@ref98]; [@ref99]). In tissues where there is no energy exchange, the water proton signal intensity is unchanged. In tissues where there is exchange in energy, the water signal intensity decreases. A low magnetization transfer ratio (MTR) is an indicator of damage to myelin and axonal membranes.

Magnetization transfer techniques have been used in Acute Disseminated Encephalomyelitis, ([@ref100]) Amyotrophic Lateral Sclerosis (ALS) ([@ref101]), MS ([@ref102]; [@ref103]; [@ref104]), and demyelination in the spinal cord ([@ref92]). Studies have also shown the possibility of using MTI to segment gray matter and white matter in the healthy adult spinal cord ([@ref105]) and in adults with chronic cervical SCI. MTR values were reported to predict sensory disability in dorsal columns while ventrolateral MTR values predicted motor disability ([@ref131]). The use of magnetization transfer in pediatric myelitis has not been reported.

Further work is needed to examine the feasibility and reliability of quantitative imaging biomarkers in children with demyelinating myelopathies. Advances in imaging have overcome many technical hindrances that once prevented analysis of the structural and functional properties of fiber tract. Current research evidence suggests that imaging can potentially be used to quantify tract injury at the acute, sub-acute and chronic phases of myelitis, discriminate between transverse myelitis and its mimics, identify subjects at high risk of developing further attacks and can also be used to monitor remyelination in clinical trials.

4.3. Ultrahigh field imaging: a possibility in pediatric myelitis {#sec4.3}
-----------------------------------------------------------------

Rapid progress in the technical improvement of MRI systems led to the introduction of ultrahigh (\>3 T) field imaging techniques. These ultrahigh field systems were developed and optimized in pursuit of the ultimate image resolution. Theoretically, signal-to-noise (SNR) ratio increases with the field strength and therefore leads to an improved diagnostic ability of MRI. Since its first introduction in the 1990s, imaging at a 7 Tesla magnetic field has gained increasing tolerability by patients and healthy volunteers ([@ref106]; [@ref107]; [@ref108]). To date, approximately 40 7 T units have been installed worldwide, although operating only in research settings ([@ref109]; [@ref110]). In a study comparing 3 T to 7 T magnetic fields, 7 T imaging showed significantly higher SNR in the spinal cord of healthy volunteers ([@ref111]). A later study revealed that 7 T MRI in combination with advanced coil technology can detect signal abnormality in the spinal corticospinal tract of patients with ALS ([@ref112]). Ultrahigh field imaging may be a useful imaging marker of demyelination. Since contrast is more enhanced at ultrahigh field strength, patients with demyelinating lesions may benefit from reduced gadolinium dosage ([@ref113]). Further work is required to investigate the utility of ultrahigh field imaging in pediatric spinal cord demyelination.

4.4. Myelin Water Fraction imaging {#sec4.4}
----------------------------------

Alterations in myelin can be measured indirectly with MRI by applying pulse sequences to detect T~2~ relaxation values present in different tissue components ([@ref114]). It is believed that T~2~ relaxation of approximately 20 ms is attributed to water contained between myelin bilayers (myelin water). The ratio of myelin water signal to total water is termed the Myelin Water Fraction (MWF) ([@ref115]). A study on measuring regional variations in myelin content along the entire spinal cord showed that MWF values were consistent with white matter and gray matter contributions in the spinal cord anatomy ([@ref116]). In a repeatability study comparing MWF values in young and older adults showed a slight decrease in MWF between the two groups ([@ref117]). In a test--retest study conducted on healthy volunteers and patients with spinal cord demyelinating lesions, high reproducibility of MWF estimates was observed in both groups, with patients showing a decrease in MWF values as compared to controls ([@ref118]). Monitoring changes in myelin content is essential in studying demyelinating diseases. Myelin water measurement has the potential to identify preserved myelin and guide trials of myelin protection and repair in demyelination lesions of the spinal cord.

### 4.4.1. Integrating measures of spinal cord dysfunction and brain dysfunction in pain {#sec4.4.1}

Recent work has used functional imaging to demonstrate connectivity between rostral brain centers ([@ref119]). A similar approach using functional white matter tractography (seeding rostral regions with known function as part of ascending pain pathways) may also be employed in patients with myelitis to map out brain regions associated with pain and other functions that are affected ([@ref120]; [@ref121]). Furthermore, in the future, by combining spinal cord with brain functional imaging, regions of the brain known to be affected in neuropathic pain in other conditions may be used to dissect the contribution of alterations in white matter tracts and the evolution of pain, a defined and necessary brain function ([@ref122]).

5. Conclusions {#sec5}
==============

Pediatric transverse myelitis is relatively uncommon. As a result, we know very little about the distinguishing characteristics of this population. Correct diagnosis for myelitis is limited by the lack of injury classification standards specific to non-traumatic SCI, and the lack of imaging techniques to define the extent of injury and preserved neurological function. Additionally, pain represents a major problem in pediatric myelitis and an obstacle to effective rehabilitation outcomes. However despite its high prevalence, very little has been described regarding the management of chronic pain in children with inflammatory demyelinating insults to the spinal cord.

Emerging quantitative MRI techniques offer unique possibilities in examining white matter integrity and myelin content in the spinal cord. DTI and MTI can be used to assess axonal integrity and the degree of demyelination. These quantitative imaging techniques may also be useful for monitoring the efficacy of new therapeutics for myelitis. However, the many advantages of quantitative imaging are accompanied by various technical challenges. The pediatric spinal cord is small in volume and subject to susceptibility and motion artifacts that must be addressed to optimize diagnostic quality. Furthermore, for these quantitative imaging techniques to be used in clinical settings, their reliability and sensitivity have to be established in pediatric myelitis.

Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health under award number K25HD079505 and by the National Institute of Neurological Disorders and Stroke (NINDS) under award number K24NS064050. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

![MRI pathological features in myelitis. Sagittal T2-weighted images of (A) 13 year old female with NMO, (B) 10 year old female with transverse myelitis and (C) 10 year old female with MS. Arrows show lesion sites.](gr1){#f0005}

![Pain pathways in spinal cord demyelinating lesions. Pain sensation follows a series of mechanisms starting from peripheral nociceptor fibers to higher cerebral structures: A- and C-nociceptor fibers synapse at the spine dorsal column, pain information is relayed through the dorsal column of the spinal cord and ascends contralaterally to the thalamus via the spinothalamic pathway. A number of cortical and subcortical regions have outputs to descending pain modulation. The rostral ventromedial medulla (RVM) receives afferent input from the periaqueductal gray (PAG), axons in the RVM project to the spinal cord dorsal horn. Demyelinating lesions can affect the peripheral nerve fibers, spinal cord columns, or the ascending/descending pathways.](gr2){#f0010}

![Schematic diagram of the pathogenesis of transverse myelitis affecting pain pathways. Top: macroscopic changes leading to altered spinal cord fiber myelination; in cases that affect the pain pathways (e.g., spinothalamic tracts), pain may be a major symptom in transverse myelitis. Bottom: microscopic changes in the spinal cord. A series of events leading to demyelination are believed to start by exposure to antigens, activation of lymphocytes and immunoglobulins, followed by eosinophils and neutrophils and astrocyte pathology (adapted from [@ref63] and [@ref62]). Macrophages may 'attack' astrocytes and myelin, leading to local inflammation, oligodendrocyte death and myelin loss. Exposed axons may thus have abnormal irritability (ectopic firing) and conduction patterns.](gr3){#f0015}

###### 

Incidence rates and etiology in non-traumatic spinal cord injuries.

              Sample characteristics   Etiology (n)   Pain assessment                                              
  ----------- ------------------------ -------------- ----------------- ----- --------------- ---- --------------- -------------------
  [@ref123]   86                       61.2           1:1               10    7               22   Not available   Not performed
  [@ref124]   177                      54.0           1.7:1             40    36              39   61              Reported by 42%
  [@ref1]     330                      55.2           1.7:1             63    81              81   60              Not performed
  [@ref126]   70                       69.0           0.8:1             12    10              23   18              Not performed
  [@ref2]     297                      32.0           1.07:1            192   3               85   Not available   Reported by 49.3%
  [@ref3]     68                       8.3            1.8:1             15    Not available   40   Not available   Not performed

###### 

Quantitative imaging findings in the healthy spinal cord. WM: white matter. GM: gray matter.

  -----------------------------------------------------------------------------------------------------------------------------------------
              Sample characteristics   Imaging results                                                                       
  ----------- ------------------------ ----------------- ----------------------- ------------------------------------------- --------------
  [@ref78]    N = 13                   29.5              Cervical and thoracic   FA (WM) = 0.68\                             Not assessed
                                                                                 FA (GM) = 0.47 MD = 0.83 × 10^−3^ mm^2^/s   

  [@ref83]    N = 4                    Not reported      Full spinal cord        FA (C5) 0.75\                               Not assessed
                                                                                 FA (T5) =0.69\                              
                                                                                 FA (L) =0.63                                

  [@ref130]   N = 1                    31.5              Cervical                FA = 0.67\                                  Not assessed
                                                                                 AD = 1.73 × 10^−3^ mm^2^/s\                 
                                                                                 RD = 0.49 × 10^−3^ mm^2^/s                  

  [@ref131]   N = 14                   45                Cervical                FA = 0.6\                                   32.2
                                                                                 AD = 1.68 × 10^−3^ mm^2^/s\                 
                                                                                 RD = 0.61 × 10^−3^ mm^2^/s                  

  [@ref132]   N = 25                   13.3              Cervical                FA = 0.5\                                   Not assessed
                                                                                 AD = 0.97 × 10^−3^ mm^2^/s\                 
                                                                                 RD = 0.41 × 10^−3^ mm^2^/s                  

  [@ref87]    N = 28                   58                Cervical                FA = 0.64                                   Not assessed
  -----------------------------------------------------------------------------------------------------------------------------------------

###### 

Quantitative imaging findings and clinical correlations in spinal cord disease.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
              Sample characteristics   Imaging results   Clinical correlations                                                                                       
  ----------- ------------------------ ----------------- ----------------------- ----------------------- ----------------------------- -------------- -------------- --------------
  [@ref93]    N = 15                   42.5              Myelitis                Cervical and thoracic   FA (lesion) = 0.59            Not assessed   Not assessed   Not assessed

  [@ref134]   N = 10                   45                Transverse myelitis     Cervical                FA (lesion) = 0.53            Not assessed   Not assessed   Not assessed

  [@ref130]   N = 25                   39.7              Traumatic SCI           Cervical                FA = 0.49\                    Not assessed   Yes            Not assessed
                                                                                                         AD = 1.28 × 10^−3^ mm^2^/s\                                 
                                                                                                         RD = 0.60 × 10^−3^ mm^2^/s                                  

  [@ref131]   N = 14                   45                Traumatic SCI           Cervical                FA = 0.48\                    26.5           Yes            Not assessed
                                                                                                         AD = 1.51 × 10^−3^ mm^2^/s\                                 
                                                                                                         RD = 0.73 × 10^−3^ mm^2^/s                                  

  [@ref132]   N = 1                    11                Transverse myelitis     Cervical                FA = 0.45\                    Not assessed   Yes            Not assessed
                                                                                                         AD = 1.06 × 10^−3^ mm^2^/s\                                 
                                                                                                         RD = 0.51 × 10^−3^ mm^2^/s                                  

  [@ref87]    N = 19                   59.7              Traumatic SCI           Cervical                FA (C2) = 0.61\               Not assessed   Yes            Not assessed
                                                                                                         FA (C5) = 0.53                                              

  [@ref138]   N = 10                   14                Traumatic SCI           Cervical                FA = 0.28\                    Not assessed   Yes            Not assessed
                                                                                                         AD = 1.15 × 10^−3^ mm^2^/s\                                 
                                                                                                         RD = 0.80 × 10^−3^ mm^2^/s                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
